Pacific Biosciences of California Inc
Change company Symbol lookup
Select an option...
PACB Pacific Biosciences of California Inc
BHR Braemar Hotels & Resorts Inc
ESALY Eisai Co Ltd
CNX CNX Resources Corp
WW WW International Inc
IBM International Business Machines Corp
NEP Nextera Energy Partners LP
TMP Tompkins Financial Corp
MFM MFS Municipal Income Trust
HMNKF HMS Networks AB
Go

Health Care : Life Sciences Tools & Services | Small Cap Blend
Company profile

Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule, Real-Time (SMRT) technology enables single molecule, real-time detection of biological processes. It offers The SMRT Cell, Phospholinked nucleotides and The PacBio RS II and Sequel instruments. Its SMRT technology enables the observation of deoxyribonucleic acid (DNA) synthesis as it occurs in real-time by harnessing the natural process of DNA replication, which is actuated by the DNA polymerase. Its phospholinked nucleotides have a fluorescent dye attached to the phosphate chain of the nucleotide rather than to the base. The PacBio RS II and Sequel instruments include optics, automated liquid handling, a touchscreen control interface and computational hardware and software.

Closing Price
$13.90
Day's Change
0.125 (0.91%)
Bid
--
Ask
--
B/A Size
--
Day's High
13.91
Day's Low
13.33
Volume
(Light)
Volume:
2,359,738

10-day average volume:
4,980,178
2,359,738

Display:

Providers:

UpdateCancel
6 providers
October 22, 2020
Invitae and Pacific Biosciences Collaborate to Develop Whole Genome Sequencing-Based Assays for Pediatric Epilepsy Diagnostics

Invitae Corporation (NYSE: NVTA), a leading genetics company, and Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced a research...(Globe Newswire)

October 19, 2020
Pacific Biosciences of California, Inc. Third Quarter 2020 Financial Results Call

Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Third Quarter 2020 Financial Results on Monday, November 2, 2020, at 4:30pm Eastern Time. (Globe Newswire)

October 15, 2020
Children's Mercy Kansas City Teams Up with Pacific Biosciences to Fight Rare Disease

Children's Mercy Kansas City, one of the nation's top pediatric medical systems, and Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced a...(Globe Newswire)

October 12, 2020
Global Population Sequencing Market: Focus on Product, Method, Technology, Application, Country, and Competitive Landscape - Analysis and Forecast, 2020-2030

Read the full report: https://www.reportlinker.com/p05976742/?utm_source=PRN Market Segmentation - Product Type - Kits and Assays, Platforms, Software Tools - Application- Human Health, Molecular Forensics, Blockchain in Genomics - Methods- Whole...(PR Newswire)

October 05, 2020
Pacific Biosciences Launches the Sequel IIe System to Accelerate Adoption of Highly Accurate HiFi Sequencing

Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced the launch of the Sequel IIe System, the next instrument evolution based on the...(Globe Newswire)

September 14, 2020
Pacific Biosciences Announces New Chief Financial Officer

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced the appointment of Susan G. Kim as Chief Financial Officer, effective as of September...(Globe Newswire)

August 11, 2020
Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock

Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("Pacific Biosciences" or the "Company") today announced that it has priced its previously announced underwritten public offering of 19,430,000 shares of its common stock at a price to the...(Globe Newswire)

Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock

Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it intends to offer and sell $75.0 million of shares of its common stock in an underwritten public offering. Pacific Biosciences also intends to grant the underwriters a...(Globe Newswire)

August 07, 2020
Pacific Biosciences Announces New Chief Executive Officer

Christian O. Henry Named Chief Executive Officer John F. Milligan, Ph.D. Named Chairman of the Board Ben Gong Named Interim CFO Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes...(Globe Newswire)

August 03, 2020
Pacific Biosciences of California, Inc. Announces Second Quarter 2020 Financial Results

Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its second quarter ended June 30, 2020. Total revenue for the second quarter of 2020 was $17.1 million, compared with $24.6 million for the same period of...(Globe Newswire)

Pacific Biosciences and Asuragen Collaborate to Develop Assays for Carrier Screening and other Applications Based on SMRT Sequencing Technology and AmplideX PCR Chemistry

Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, and Asuragen, a molecular diagnostics company delivering easy-to-use products for complex testing in...(BusinessWire)

Pacific Biosciences and Asuragen Collaborate to Develop Assays for Carrier Screening and other Applications Based on SMRT Sequencing Technology and AmplideX PCR Chemistry

Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, and Asuragen, a molecular diagnostics company delivering easy-to-use products for complex testing in...(Globe Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.